tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

168 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

14.45%9.68%12.20%63.68%
14.45% Insiders
12.20% Other Institutional Investors
63.68% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail and individual investors. Approximately 21.87% of the company’s stock is owned by Institutional Investors, 14.45% is owned by Insiders and 63.68% is owned by Public Companies and Individual Investors.
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail and individual investors. Approximately 21.87% of the company’s stock is owned by Institutional Investors, 14.45% is owned by Insiders and 63.68% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 05, 2024Sold$10546200
May 11, 2023Bought$13600000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$380259

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,787,914Institution9.36%126,353,050
4,163,211Institution8.14%109,867,138
2,219,467Institution4.34%58,571,734
1,962,057Institution3.84%51,778,684
1,599,724Institution3.13%42,216,716
1,317,285Institution2.57%34,763,151
1,026,642Institution2.01%27,093,082
650,000Institution1.27%17,153,500
438,132Institution0.86%11,562,303
424,002Institution0.83%11,189,413

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,599,724Institution3.13%42,216,716
1,026,642Institution2.01%27,093,082
438,132Institution0.86%11,562,303
424,002Institution0.83%11,189,413
354,567Institution0.69%9,357,023
301,914Institution0.59%7,967,510
153,792Institution0.30%4,058,571
108,533Institution0.21%2,864,186
83,756Institution0.16%2,210,321
65,778Institution0.13%1,735,881

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,473,812Institution2.88%46,955,650
1,269,428Institution2.48%32,053,057
954,892Institution1.87%25,199,600
553,799Institution1.08%17,644,036
344,780Institution0.67%9,098,744
316,995Institution0.62%8,365,498
151,956Institution0.30%4,841,318
174,209Institution0.34%4,398,777
113,568Institution0.22%2,867,592
88,467Institution0.17%2,334,644

FAQ

Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 12.20% of the company's stock is held by institutional investors, 14.45% is held by insiders, and 63.68% is held by retail investors.
    What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 12.20% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.68% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
        Andreas Halvorsen owns the most shares of 4D Molecular Therapeutics (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis